
Strongbridge Biopharma plc SBBP
Strongbridge Biopharma plc Operating Cycle | SBBP
Annual Operating Cycle Strongbridge Biopharma plc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 13.9 | 19.1 | 28.7 | 28.6 | 22.8 | 20 | 22.3 | 32.1 | 27.7 | 24 | 11.6 |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.1 | 11.6 | 22.8 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enanta Pharmaceuticals
ENTA
|
37.8 | $ 11.61 | 3.46 % | $ 248 K | ||
|
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
206 | $ 95.42 | 0.42 % | $ 7.08 B | ||
|
Lipocine
LPCN
|
3.76 M | $ 1.59 | -0.31 % | $ 8.66 M | ||
|
PTC Therapeutics
PTCT
|
646 | $ 64.91 | 1.2 % | $ 5.16 B | ||
|
Madrigal Pharmaceuticals
MDGL
|
35.9 | $ 432.77 | 0.04 % | $ 9.71 B | ||
|
MeiraGTx Holdings plc
MGTX
|
8.31 | $ 9.68 | 0.57 % | $ 779 M | ||
|
Processa Pharmaceuticals
PCSA
|
723 | $ 1.85 | -1.07 % | $ 2.42 M | ||
|
Eton Pharmaceuticals
ETON
|
189 | $ 68.4 | 1.27 % | $ 1.84 B | ||
|
Protalix BioTherapeutics
PLX
|
358 | $ 3.13 | 9.44 % | $ 246 M | ||
|
Kamada Ltd.
KMDA
|
269 | $ 8.1 | 0.43 % | $ 467 M | ||
|
Neurocrine Biosciences
NBIX
|
517 | $ 173.86 | 2.79 % | $ 17.3 B | ||
|
Maravai LifeSciences Holdings
MRVI
|
172 | $ 7.71 | -1.91 % | $ 1.11 B | ||
|
Lexicon Pharmaceuticals
LXRX
|
362 | $ 1.86 | 1.34 % | $ 675 M | ||
|
Nurix Therapeutics
NRIX
|
28.4 | $ 16.46 | 3.65 % | $ 1.43 B | ||
|
MacroGenics
MGNX
|
21.6 | $ 2.33 | -3.85 % | $ 147 M | ||
|
Novo Nordisk A/S
NVO
|
426 | $ 41.06 | 0.88 % | $ 182 B | ||
|
Oragenics
OGEN
|
250 | $ 0.35 | 1.4 % | $ 755 K | ||
|
Precigen
PGEN
|
201 | $ 4.75 | 4.98 % | $ 1.49 B | ||
|
Avidity Biosciences
RNA
|
18.5 | $ 7.97 | -3.22 % | $ 1.1 B |